UsefulLinks
Biology
Human Biology
Biology of Aging
1. Introduction to Biogerontology
2. Theories of Aging
3. The Hallmarks of Aging: Molecular and Cellular Mechanisms
4. Systemic and Organismal Aging
5. Aging and Major Diseases
6. Interventions to Modulate the Aging Process
7. Measuring Biological Age
8. Future Directions and Societal Implications
8.
Future Directions and Societal Implications
8.1.
Regenerative Medicine and Tissue Engineering
8.1.1.
Advances in tissue regeneration
8.1.1.1.
Organ-on-chip technology
8.1.1.2.
Bioprinting applications
8.1.1.3.
Scaffold development
8.1.2.
Organ replacement strategies
8.1.2.1.
Xenotransplantation
8.1.2.2.
Artificial organs
8.1.2.3.
Tissue-engineered organs
8.1.3.
Clinical translation challenges
8.2.
The Concept of Longevity Escape Velocity
8.2.1.
Definition and implications
8.2.2.
Technological requirements
8.2.2.1.
Comprehensive rejuvenation
8.2.2.2.
Damage repair
8.2.2.3.
Prevention strategies
8.2.3.
Timeline predictions
8.2.4.
Scientific skepticism
8.3.
Emerging Technologies
8.3.1.
Artificial intelligence in aging research
8.3.1.1.
Drug discovery
8.3.1.2.
Biomarker identification
8.3.1.3.
Personalized interventions
8.3.2.
Nanotechnology applications
8.3.3.
Gene editing advances
8.3.3.1.
CRISPR applications
8.3.3.2.
Base editing
8.3.3.3.
Prime editing
8.4.
Ethical, Legal, and Social Implications (ELSI)
8.4.1.
Equity and Access to Therapies
8.4.1.1.
Disparities in healthcare
8.4.1.2.
Global considerations
8.4.1.3.
Resource allocation
8.4.1.4.
Justice and fairness
8.4.2.
Economic Impact
8.4.2.1.
Healthcare costs
8.4.2.1.1.
Treatment expenses
8.4.2.1.2.
Long-term care
8.4.2.2.
Societal productivity
8.4.2.2.1.
Extended working years
8.4.2.2.2.
Pension systems
8.4.2.3.
Insurance implications
8.4.3.
Philosophical Considerations of Extended Lifespan
8.4.3.1.
Quality of life
8.4.3.1.1.
Healthspan vs lifespan
8.4.3.1.2.
Meaning and purpose
8.4.3.2.
Societal and cultural impacts
8.4.3.2.1.
Intergenerational relationships
8.4.3.2.2.
Social structures
8.4.3.2.3.
Cultural adaptation
8.4.3.3.
Identity and continuity
8.4.4.
Regulatory Frameworks
8.4.4.1.
FDA approval processes
8.4.4.2.
International harmonization
8.4.4.3.
Safety standards
8.4.5.
Research Ethics
8.4.5.1.
Human subjects protection
8.4.5.2.
Informed consent
8.4.5.3.
Risk-benefit analysis
Previous
7. Measuring Biological Age
Go to top
Back to Start
1. Introduction to Biogerontology